Leukapheresis Products Market Research Report: By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Provider and Blood Center, Other) -Forecast Till 2027
ID: MRFR/MED/5303-HCR | February 2021 | Region: Global | 90 pages
Speak to Analyst
Request a Free Sample
Leukapheresis Products Market Scenario:
Leukapheresis products market is expected to grow significantly over the forecast period. Leukapheresis products market is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.
Leukapheresis is a procedure of removing abnormal white blood cells (WBCs) from the blood. Leukapheresis can be used as a treatment for certain types of leukemia or as the first step of chimeric antigen receptor (CAR) T-cell therapy. The growing number of blood donations, increasing prevalence of leukaemia, and demand for leukapheresis products in clinical research are some factors that are anticipated to propel the growth of the market. According to the Facts and Figures 2017-2018 by the Leukemia and Lymphoma Society, an estimated 1,345,123 people in the US are living with or in remission from leukemia, lymphoma or myeloma. On the other hand, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hinder the market growth over the forecast period.
Segmentation:
The leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.
The market, on the basis of application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukapheresis products market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European leukapheresis products market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The leukapheresis products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukapheresis products market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the leukapheresis products market.
Regional Market Summary:
Global Leukapheresis Products Market Share (%), by Region, 2017 
Source: America’s Blood Centers, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the leukapheresis products market owing to the growing number of blood donations, rising incidence and prevalence of leukaemia and growing demand for leukopaks in clinical research. According to the America’s Blood Centers, more than 15 million pints of blood are transfused in the US each year.
Europe is expected to hold the second largest position in the leukapheresis products market. The market growth in this region is attributed to the increasing prevalence of leukemia and well-developed healthcare sector in the region. According to the Cancer Research UK, about 9,900 new cases of leukaemia were reported in UK in 2015.
The leukapheresis products market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major multinational pharma and biotech companies, and improvement in healthcare access.
The Middle East & Africa has the lowest share of the leukapheresis products market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Leukapheresis Products Market, by Type
- Leukapheresis Devices
- Apheresis Devices
- Leukapheresis Columns & Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
Leukapheresis Products Market, by Application
- Research Applications
- Therapeutic Applications
Leukapheresis Products Market, by End User
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Others
Leukapheresis Products Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Leukapheresis Products Market, by Key Players
- Haemonetics
- Terumo BCT
- Asahi Kasei Medical
- STEMCELL Technologies
- Macopharma
- Caltag Medsystem
- ZENBIO
- Fresenius Kabi
- PPA Research Group
- StemExpress
- HemaCare Corporation
- ALLCells, LLC
- Others
Intended Audience
- Apheresis Device Manufacturers and Distributors
- Leukapheresis Product Manufacturers and Distributors
- Pharmaceutical and Biotechnological Companies
- Healthcare Service Providers (including Hospitals and Transfusion Centers)
- Cancer Treatment Centers
- Blood Component Providers & Blood Centers
- Contract Research Organizations
- Academic and Research Institutes
- Government Associations
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 7.7% (2017-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application and End user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The leukapheresis products market is projected to grow at a 7.7% CAGR between 2018-2023.
The Americas is projected to command the largest share in the leukapheresis products market.
Rising prevalence of leukemia is boosting market growth.
High cost may limit market growth.
Different strategies used by market players to create a dominance in the leukapheresis products market include product launches, collaborations, strategic alliances, and others.
